People In Brief
This article was originally published in The Gray Sheet
Executive Summary
Medtronic shuffle: Former Vascular Business President William Hawkins takes over as firm's president & COO May 3. Hawkins' new responsibilities include ensuring robust development of Medtronic's worldwide product lines and geographic operating units. Current CEO Art Collins was the last to occupy the COO position in 2001. Scott Ward supplants Hawkins, taking control of Medtronic's DES development program. The firm expects to present 12-month Endeavor I DES data at the Paris Course on Revascularization meeting May 25-28. Separately, Ward, who previously led Medtronic's neurological and diabetes businesses, says that Medtronic "is positioned to launch the world's first artificial pancreas in the next 12-18 months"...
You may also be interested in...
Navigant Pathogen Inactivation System Catching Up With Cerus, Vitex
Navigant Biotechnologies is dedicating $10 mil. in 2004 to the development of its Mirasol riboflavin-based pathogen reduction technology (PRT) for platelets and red blood cells
Boston Scientific To Market Celsion’s Prolieve BPH Device Immediately
Boston Scientific will promote Celsion's Prolieve microwave urethroplasty system as a less-painful alternative to existing treatments for benign prostatic hyperplasia (BPH), following FDA approval Feb. 19
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.